Incyte Corp. plans to lease temporarily space across the state line in Pennsylvania.
Incyte spokesperson Catalina Loveman said a report on Friday in the Philadelphia Business Journal was incorrect.
The story indicated the company was moving jobs to space at the former headquarters of Endo Pharmaceuticals and seemed to hold open the possibility of a change in plans by the company.
Loveman said the lease is temporary for the company, which has run out of space at its current location in Delaware.
“We looked at space locally as well but were unable to find something that was available to accommodate our space and timing needs,” Loveman said.
Suburban space near Incyte’s headquarters has been in short supply as companies fill up locations like the former Rollins high-rise building on Concord Pike.
Also, one short to mid-term lease office park in the area, Concord Plaza, is being converted into office-residential space, with its tenants leasing other space in the area.
Incyte earlier disclosed plans to acquire its headquarters – a former Wanamakers department store on Augustine Cut Off – just outside Wilmington for nearly $80 million. The site is owned by Capano family interests.
Incyte has also filed plans with New Castle County to add office space at the site to handle the growth.
Incyte’s office campus was reportedly near capacity when the company moved to the site in 2014 from the DuPont Experimental Station.
The State of Delaware worked hard to keep Incyte in the state after major cuts at AstraZeneca. AZ shut down and demolished research and development facilities in Delaware as it shifted that work to other sites in recent years.
Incyte has been growing thanks to the success of its Jackafi, a drug that fights certain types of blood cancers. The company is doing research work on other cancer drugs.
The report of jobs moving to Pennsylvania came at a time when the state was reeling from news of a merger between Dow and DuPont.
The Philadelphia Business Journal did little to quiet the concern with a headline on a story – DuPont-Dow merger ‘catastrophic’ for Delaware.
The headline referred to comments by Republican Party Chairman Charles Copeland, who used the term. Copeland is a DuPont, family member.
On Friday, DuPont also announced plans to cut its worldwide workforce by 10 percent.